Appia Bio Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Appia Bio's estimated annual revenue is currently $8.8M per year.(i)
  • Appia Bio's estimated revenue per employee is $155,000

Employee Data

  • Appia Bio has 57 Employees.(i)
  • Appia Bio grew their employee count by 33% last year.

Appia Bio's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Regulatory AffairsReveal Email/Phone
3
VP Head Quality at Appia BioReveal Email/Phone
4
Head Human Resources, ConsultantReveal Email/Phone
5
SVP, Technical OperationsReveal Email/Phone
6
VP, Head Regulatory AffairsReveal Email/Phone
7
VP, QualityReveal Email/Phone
8
Director, Engineering, Facilities, OperationsReveal Email/Phone
9
Sr Director ResearchReveal Email/Phone
10
Senior DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Appia Bio?

keywords:N/A

N/A

Total Funding

57

Number of Employees

$8.8M

Revenue (est)

33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Appia Bio News

2022-04-17 - Kite Receives US FDA Approval of New State-of-the-Art CAR T-Cell ...

... pipeline deals for the next generation of cell therapies, including previously announced deals with Appia Bio and Shoreline Biosciences.

2022-04-17 - Global Cancer Stem Cells Market Estimated to Surpass

Appia Bio is highly focused on discovering as well as developing off-the-shelf (OTS) allogeneic cell therapies across a wide array of cancer...

2022-04-06 - FDA Approves Kite Pharma’s Cancer Drug Yescarta

Culver City-based Appia Bio, meanwhile, emerged from stealth last spring to create off-the-shelf cell therapies that can be delivered quicker and cheaper to...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.1M5716%N/A
#2
$6.3M572%N/A
#3
$6.9M570%N/A
#4
$14.3M574%N/A
#5
$3.5M572%N/A